These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21291404)

  • 1. PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis.
    Guzińska-Ustymowicz K; Pryczynicz A
    Anticancer Agents Med Chem; 2011 Jan; 11(1):99-108. PubMed ID: 21291404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
    Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
    Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC; Wong PC; Pallen CJ
    Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
    Reich R; Hadar S; Davidson B
    Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
    Miskad UA; Semba S; Kato H; Yokozaki H
    Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
    Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
    Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
    Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
    Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Ustymowicz M
    Adv Med Sci; 2011; 56(1):39-43. PubMed ID: 21555304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
    Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
    Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
    Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
    Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
    BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phosphatase PRL-3 Is Involved in Key Steps of Cancer Metastasis.
    Duciel L; Monraz Gomez LC; Kondratova M; Kuperstein I; Saule S
    J Mol Biol; 2019 Aug; 431(17):3056-3067. PubMed ID: 31207239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression.
    Shi Y; Xu S; Ngoi NYL; Hui Y; Ye Z
    Biochem Biophys Res Commun; 2021 Oct; 576():108-116. PubMed ID: 34482023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.